AI assistant
Sending…
Solid Biosciences Inc. — Director's Dealing 2018
Jul 27, 2018
33003_dirs_2018-07-26_898ac7dd-fdcc-488c-8e99-155814559aab.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2018-07-25
Reporting Person: Ganot Ilan (Director, CEO & President)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-07-25 | Employee Stock | |||||||
| Option (Right to Buy) | $37.89 | A | 193000 | Acquired | 2028-07-25 | Common Stock (193000) | Direct |
Footnotes
F1: This option was granted on July 25, 2018 and vests in four equal annual installments on the anniversary of the grant date.
More from Solid Biosciences Inc.
Interim / Quarterly Report
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 10
Regulatory Filings
2026
Mar 19
Annual Report
2026
Mar 19
Major Shareholding Notification
2026
Mar 17
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19